DOCSLIB.ORG

The Effect of Platelet-Rich Plasma in Bone-Tendon Integration

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Effect of Platelet-Rich Plasma in Bone-Tendon Integration Advances in Clinical and Experimental Medicine BIMONTHLY ISSN 1899-5276 (PRINT) ISSN 2451-2680 (ONLINE) www.advances.umed.wroc.pl 2017, Vol. 26, No. 2 (March–April) Impact Factor (IF) – 1.127 Ministry of Science and Higher Education – 15 pts. Index Copernicus (ICV) – 169.43 pts. Advances in Clinical and Experimental Medicine ISSN 1899-5276 (PRINT) ISSN 2451-2680 (ONLINE) www.advances.umed.wroc.pl BIMONTHLY 2017 Advances in Clinical and Experimental Medicine is a peer-reviewed open access journal published Vol. 26, No. 2 by Wroclaw Medical University. Its abbreviated title is Adv Clin Exp Med. Journal publishes original (March–April) papers and reviews encompassing all aspects of medicine, including molecular biology, bioche- mistry, genetics, biotechnology and other areas. It is published bimonthly, one volume per year. Editor-in-Chief Secretary Editorial Office Maciej Bagłaj Katarzyna Neubauer ul. Marcinkowskiego 2–6 50-368 Wrocław, Poland Vice-Editor-in-Chief Tel.: +48 71 784 12 05 Dorota Frydecka E-mail: [email protected] Editorial Board Piotr Ponikowski Piotr Dzięgiel Marek Sąsiadek Publisher Marian Klinger Leszek Szenborn Wroclaw Medical University Halina Milnerowicz Jacek Szepietowski Wybrzeże L. Pasteura 1 Jerzy Mozrzymas 50-367 Wrocław, Poland Thematic Editors Statistical Editors Dorota Diakowska, Leszek Noga, © Copyright by Wroclaw Medical University, Marzenna Bartoszewicz (Microbiology) Wrocław 2017 Marzena Dominiak (Dentistry) Lesław Rusiecki Paweł Domosławski (Surgery) Technical Editorship Online edition is the original version of the journal Maria Ejma (Neurology) Paulina Kunicka, Alicja Wojciechowska Jacek Gajek (Cardiology) Katarzyna Kapelko-Słowik (Internal medicine) English Language Copy Editors Mariusz Kusztal Sherill Howard Pociecha, Jason Schock, (Nephrology and Transplantology) Marcin Tereszewski Rafał Matkowski (Oncology) Robert Śmigiel (Pediatrics) Paweł Tabakow (Experimental medicine) Anna Wiela-Hojeńska (Pharmaceutical Sciences) Ewa Zuba-Surma (Basic Sciences) International Advisory Board Pavel Kopel (Czech Republic) Reinhard Berner (Germany) Tomasz B. Owczarek (USA) Vladimir Bobek (Czech Republic) Ivan Rychlík (Czech Republic) Marcin Czyz (England) Anton Sculean (Switzerland) Buddhadeb Dawn (USA) Andriy B. Zimenkovsky (Ukraine) Kishore Kumar Jella (USA) Editorial Policy Advances in Clinical and Experimental Medicine (Adv Clin Exp Med) is an independent multidisciplinary forum for exchange of scientific and clinical information, publishing original research and news encompassing all aspects of medicine including molecular biology, biochemistry, genetics, biotechnology and other areas. During the review process, the Editorial Board conforms to the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication” approved by the International Committee of Medical Journal Editors (www.ICMJE.org/). The journal publishes (in English only) original papers and reviews. Short works considered original, novel and significant are given priority. Experimental studies must include a statement that the experimental protocol and informed consent procedure were in compliance with the Helsinki Convention and were approved by ethics committee. For all subscription related queries please contact our Editorial Office: [email protected] For more information visit the journal’s website: www.advances.umed.wroc.pl Pursuant to the ordinance no. 13/XV R/2017 of the Rector of Wroclaw Medical University (as of February 7, 2017) from February 8, 2017 authors are required to pay a fee amounting to 300 euros for each manuscript accepted for publication in the journal Advances in Clinical and Experimental Medicine. Indexed in: MEDLINE, Science Citation Index Expanded, Journal Citation Reports/Science Edition, Scopus, EMBASE/Excerpta Medica, Ulrich’sTM International Periodicals Directory, Index Copernicus Typographic design: Monika Kolęda, Piotr Gil Cover: Monika Kolęda DTP: TYPO-GRAF Circulation: 120 copies Advances in Clinical and Experimental Medicine ISSN 1899-5276 (PRINT) ISSN 2451-2680 (ONLINE) BIMONTHLY 2017, Vol. 26, No. 21 (March–April) www.advances.umed.wroc.pl Contents 187 New Members of the International Advisory Board Original papers 193 İsmail Ağır, Mahmut Nedim Aytekin, Fatih Küçükdurmaz, Barış Kocaoğlu, Sule Çetinel, Mustafa Karahan The effect of platelet-rich plasma in bone-tendon integration 201 Zhou Xin Yang, Gen Xiang Mao, Jing Zhang, Xiao Lin Wen, Bing Bing Jia, Yi Zhong Bao, Xiao Ling Lv, Ya Zhen Wang, Guo Fu Wang IFN-γ induces senescence-like characteristics in mouse bone marrow mesenchymal stem cells 207 Gulnur Kizilay, Yesim Hulya Uz, Gulay Seren, Enis Ulucam, Ali Yilmaz, Ziya Cukur, Umit Ali Kayisli In vivo effects of curcumin and deferoxamine in experimental endometriosis 215 Ewa Sawicka, Anna Długosz The role of 17β-estradiol metabolites in chromium-induced oxidative stress 223 Jacek Drobnik, Krystyna Pietrucha, Lucyna Piera, Jacek Szymański, Alicja Szczepanowska Collagenous scaffolds supplemented with hyaluronic acid and chondroitin sulfate used for wound fibroblast and embryonic nerve cell culture 231 Małgorzata Proboszcz, Magdalena Paplińska-Goryca, Patrycja Nejman-Gryz, Katarzyna Górska, Rafał Krenke A comparative study of sTREM-1, IL-6 and IL-13 concentration in bronchoalveolar lavage fluid in asthma and COPD: A preliminary study 237 Ying Jiang, Xiaodan Dai, Liping Duan, Yaou Zhou The coexistence of autoimmune rheumatic diseases and thymomas 245 Aydan Eroğlu, Cevriye Ersöz, Durdu Karasoy, Serpil Sak Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis 251 Krzysztof Hoppe, Krzysztof Schwermer, Anna Olewicz-Gawlik, Patrycja Klysz, Anna Kawka, Ewa Baum, Dorota Sikorska, Katarzyna Ścigacz, Magdalena Roszak, Bengt Lindholm, Krzysztof Pawlaczyk, Andrzej Oko Dialysis vintage and cardiovascular injury as factors influencing long-term survival in peritoneal dialysis and hemodialysis 259 Bartłomiej Szynglarewicz, Rafał Matkowski Ductal carcinomas in situ and invasive cancers detected on screening mammography: Cost-effectiveness of initial and subsequent rounds of population-based program 2007–2014 263 Grażyna Gościniak, Monika M. Biernat, Aldona Bińkowska, Agnieszka Kus, Barbara Iwańczak Frequency of infection with Helicobacter pylori isolates of different antimicrobial profiles in children and adolescents: A preliminary study 269 Tadeusz A. Dorobisz, Jerzy S. Garcarek, Jacek Kurcz, Krzysztof Korta, Andrzej T. Dorobisz, Przemysław Podgórski, Jan Skóra, Piotr Szyber Diagnosis and treatment of pelvic congestion syndrome: Single-centre experiences 277 Alina Kępka, Roman M. Janas, Sławomir A. Pancewicz, Renata Świerzbińska Serum carnitine and acyl-carnitine in patients with meningitis due to tick-borne encephalitis virus infection 281 Senay Topsakal, Fulya Akin, Sabahat Turgut, Emrah Yerlikaya, Guzin F. Yaylali Serum leptin levels and GHR-d3/fl gene polymorphism in acromegalic patients with thyroid nodules 287 Zhe Yu, Lianhe Zheng, Xiaodong Yan, Xiaoxiang Li, Jian Zhao, Bao’an Ma Closed reduction and percutaneous annulated screw fixation in the treatment of comminuted proximal humeral fractures © Copyright by Wroclaw Medical University, Wrocław 2017 186 Contents 295 Paweł Krzesiński, Beata Uziebło-Życzkowska, Grzegorz Gielerak, Adam Stańczyk, Katarzyna Piotrowicz, Wiesław Piechota, Paweł Smurzyński, Andrzej Skrobowski Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome 303 Onur Turan, Deniz Turgut, Turkan Gunay, Erkan Yilmaz, Ayse Turan, Atila Akkoclu The contribution of clinical assessments to the diagnostic algorithm of pulmonary embolism 311 Klaudia Koza, Paweł Grzelązka, Adrianna Trofimiuk, Karol Suppan, Marcin Wasielewski, Joanna Wiśniewska, Jacek Budzyński Clinical risk factors for loss of stent primary patency in patients with chronic legs ischemia 319 Joanna Kwiatkowska, Anna Wałdoch, Jarosław Meyer-Szary, Piotr Potaż, Marek Grzybiak Cardiac tumors in children: A 20-year review of clinical presentation, diagnostics and treatment 327 Ji Dai, Wenjie Jiang, Zhigang Min, Jian Yang, Yongfei Tan, Tieliang Ma, Zhijun Ge Neutrophil CD64 as a diagnostic marker for neonatal sepsis: Meta-analysis 333 Ying Xu, Wenjie Jiang, Guochang Chen, Wenjiao Zhu, Weiliang Ding, Zhijun Ge, Yongfei Tan, Tieliang Ma, Guoxing Cui L-carnitine treatment of insulin resistance: A systematic review and meta-analysis Reviews 339 Marta Wesoła, Michał Jeleń The risk of breast cancer due to PALB2 gene mutations 343 Guozhen Cui, Shaoyan Zhang, Jia Zou, Yang Chen, Hao Chen P2Y12 receptor gene polymorphism and the risk of resistance to clopidogrel: A meta-analysis and review of the literature 351 Magdalena Kliś, Agnieszka Sławuta, Jacek Gajek Antiarrhythmic properties of atrial pacing 359 Sylwia Bednarska, Agnieszka Siejka The pathogenesis and treatment of polycystic ovary syndrome: What’s new? New Members of the International Advisory Board Reinhard Berner Reinhard Berner is Professor of Pediatrics and since 2012 Chairman and Direc­ tor of the Children’s Hospital, University Medical Center Carl Gustav Carus at the Technische Universität Dresden, Germany. His research has focused on invasive infections in newborns and (young) children. His main interest is in the (mole­ cular) epidemiology of group B and group A streptococci, viral respiratory tract infection, as well as the diagnosis of sepsis with novel technical approaches.
Load more

Recommended publications
  • 8329TFM-A Thermally Conductive Epoxy Adhesive
    8329TFM-A Thermally Conductive Epoxy Adhesive MG Chemicals UK Limited Version No: A-1.01 Issue Date:23/07/2018 Safety Data Sheet (Conforms to Regulation (EU) No 2015/830) Revision Date: 17/03/2020 L.REACH.GBR.EN SECTION 1 IDENTIFICATION OF THE SUBSTANCE / MIXTURE AND OF THE COMPANY / UNDERTAKING 1.1. Product Identifier Product name 8329TFM-A Synonyms SDS Code: 8329TFM-Part A; 8329TFM-25ML, 8329TFM-50ML Other means of identification Thermally Conductive Epoxy Adhesive 1.2. Relevant identified uses of the substance or mixture and uses advised against Relevant identified uses Thermally conductive adhesive for bonding and thermal management Uses advised against Not Applicable 1.3. Details of the supplier of the safety data sheet Registered company name MG Chemicals UK Limited MG Chemicals (Head office) Heame House, 23 Bilston Street, Sedgely Dudley DY3 1JA United Address 9347 - 193 Street Surrey V4N 4E7 British Columbia Canada Kingdom Telephone +(44) 1663 362888 +(1) 800-201-8822 Fax Not Available +(1) 800-708-9888 Website Not Available www.mgchemicals.com Email [email protected] [email protected] 1.4. Emergency telephone number Association / Organisation Verisk 3E (Access code: 335388) Not Available Emergency telephone numbers +(44) 20 35147487 Not Available Other emergency telephone +(0) 800 680 0425 Not Available numbers SECTION 2 HAZARDS IDENTIFICATION 2.1. Classification of the substance or mixture Classification according to H315 - Skin Corrosion/Irritation Category 2, H319 - Eye Irritation Category 2, H317 - Skin Sensitizer Category 1, H410 - Chronic Aquatic Hazard regulation (EC) No 1272/2008 Category 1 [CLP] [1] Legend: 1. Classified by Chemwatch; 2.
    [Show full text]
  • Pretty Scary 2 Unmasking Toxic Chemicals in Kids’ Makeup
    Prevention October 2016 Starts Here Campaign for Safe Cosmetics Pretty Scary 2 Unmasking toxic chemicals in kids’ makeup breastcancerfund.org 1 Acknowledgements Developed and published by the Breast Cancer Fund and spearheaded by their Campaign for Safe Cosmetics, this report was written by Connie Engel, Ph.D.; Janet Nudelman, MA; Sharima Rasanayagam, Ph.D.; Maija Witte, MPH; and Katie Palmer. Editing, messaging and vision were contributed by Denise Halloran and Erika Wilhelm. Sara Schmidt, MPH, MSW, coordinated the purchasing of products reviewed in this report and worked closely with partners to share the message. Thank you to James Consolantis, our contributing content specialist and Rindal&Co for design direction. WE ARE GRATEFUL FOR THE GENEROUS CONTRIBUTIONS FROM OUR FUNDERS: As You Sow Foundation, Jacob and Hilda Blaustein Foundation, Lisa and Douglas Goldman Foundation, Park Foundation, Passport Foundation, and the Serena Foundation. breastcancerfund.org 2 Our partners in purchasing products Pam Miller, Alaska Community Action on Toxics, Alaska Brooke Sarmiento, BEE-OCH Organics, Colorado Sara Schmidt, Breast Cancer Fund, California Susan Eastwood, Clean Water Action, Connecticut Anne Hulick, Clean Water Action, Connecticut Johnathan Berard, Clean Water Action, Rhode Island Lauren Carson, Clean Water Action, Rhode Island Cindy Luppi, Clean Water Action, Massachusetts Kadineyse Ramize Peña, Clean Water Action, Massachusetts Elizabeth Saunders, Clean Water Action, Massachusetts Sara Lamond, Fig & Flower, Georgia Beverly Johnson,
    [Show full text]
  • Thesis for Word XP
    From THE INSTITUTE OF ENVIRONMENTAL MEDICINE Karolinska Institutet, Stockholm, Sweden DIETARY CADMIUM EXPOSURE AND THE RISK OF HORMONE-RELATED CANCERS Bettina Julin Stockholm 2012 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by Larserics Digital Print AB, 2012 © Bettina Julin, 2012 ISBN 978-91-7457-710-5 ABSTRACT The toxic metal cadmium has been widely dispersed into the environment mainly through anthropogenic activities. Even in industrially non-polluted areas, farmland and consequently foods are, to a varying degree, contaminated. Food is the main source of exposure besides tobacco smoking. Cadmium accumulates in the body, particularly in the kidney where it may cause renal tubular damage. Recently, cadmium was discovered to possess endocrine disrupting properties, mainly mimicking the in vivo- effects of estrogen. The metal is classified as a human carcinogen by the International Agency for Research on Cancer based on lung cancer studies of occupational inhalation. It is, however, not clear whether cadmium exposure via the diet may cause cancer. Possible health consequences related to estrogenic effects such as increased risk of hormone-related cancers are virtually unexplored. The aims of this thesis were to: 1) estimate the dietary exposure to cadmium, 2) estimate cadmium’s toxicokinetic variability using a population model and to establish the link between urinary cadmium concentrations (a biomarker of accumulated kidney cadmium) and the corresponding long-term dietary exposure to cadmium in the population, 3) evaluate the comparability between food frequency questionnaire (FFQ)-based estimates of dietary cadmium exposure and urinary cadmium concentrations and 4) prospectively assess the association between dietary cadmium exposure and incidence of hormone-related cancers (endometrial, breast, ovarian and prostate cancers) in two population-based cohorts consisting of around 60 000 Swedish women and 40 000 men.
    [Show full text]
  • Metalloestrogens: an Emerging Class of Inorganic Xenoestrogens with Potential to Add to the Oestrogenic Burden of the Human Breast
    JOURNAL OF APPLIED TOXICOLOGY METALLOESTROGENS J. Appl. Toxicol. (In press) Published online in Wiley InterScience (www.interscience.wiley.com) DOI: 10.1002/jat.1135 Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast P. D. Darbre* School of Biological Sciences, The University of Reading, Reading RG6 6AJ, UK Received 28 October 2005; Revised 6 December 2005; Accepted 6 December 2005 ABSTRACT: Many compounds in the environment have been shown capable of binding to cellular oestrogen receptors and then mimicking the actions of physiological oestrogens. The widespread origin and diversity in chemical structure of these environmental oestrogens is extensive but to date such compounds have been organic and in particular phenolic or carbon ring structures of varying structural complexity. Recent reports of the ability of certain metal ions to also bind to oestrogen receptors and to give rise to oestrogen agonist responses in vitro and in vivo has resulted in the realisation that environmental oestrogens can also be inorganic and such xenoestrogens have been termed metalloestrogens. This report highlights studies which show metalloestrogens to include aluminium, antimony, arsenite, barium, cadmium, chro- mium (Cr(II)), cobalt, copper, lead, mercury, nickel, selenite, tin and vanadate. The potential for these metal ions to add to the burden of aberrant oestrogen signalling within the human breast is discussed. Copyright © 2006 John Wiley & Sons, Ltd. KEY WORDS: oestrogen; metalloestrogen; environmental oestrogen; xenoestrogen; cadmium; aluminium; smoking; antiperspi- rant; breast cancer Introduction endocrine disruption in wildlife are being measured (Matthiessen, 2003) but the impact on human health re- Over recent years, many compounds in the environment mains a subject for research (Darbre, 2006a).
    [Show full text]
  • Hormonal Activation of Genes Through Nongenomic
    HORMONAL ACTIVATION OF GENES THROUGH NONGENOMIC PATHWAYS BY ESTROGEN AND STRUCTURALLY DIVERSE ESTROGENIC COMPOUNDS A Dissertation by XIANGRONG LI Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY May 2005 Major Subject: Toxicology HORMONAL ACTIVATION OF GENES THROUGH NONGENOMIC PATHWAYS BY ESTROGEN AND STRUCTURALLY DIVERSE ESTROGENIC COMPOUNDS A Dissertation by XIANGRONG LI Submitted to Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Approved as to style and content by: _______________________________ _______________________________ Stephen H. Safe Weston W. Porter (Chair of Committee) (Member) _______________________________ _______________________________ Robert C. Burghardt Timothy D.Phillips (Member) (Chair of Toxicology Faculty) _______________________________ _______________________________ Kirby C. Donnelly Glen A. Laine (Member) (Head of Department) May 2005 Major Subject: Toxicology iii ABSTRACT Hormonal Activation of Genes through Nongenomic Pathways by Estrogen and Structurally Diverse Estrogenic Compounds. (May 2005) Xiangrong Li, B.S., Wuhan University Chair of Advisory Committee: Dr. Stephen H. Safe Lactate dehydrogenase A (LDHA) is hormonally regulated in rodents, and increased expression of LDHA is observed during mammary gland tumorigenesis. The mechanisms of hormonal regulation of LDHA were investigated in breast cancer cells using a series of deletion and mutant reporter constructs derived from the rat LDHA gene promoter. Results of transient transfection studies showed that the -92 to -37 region of the LDHA promoter was important for basal and estrogen-induced transactivation, and mutation of the consensus CRE motif (-48/-41) within this region resulted in significant loss of basal activity and hormone-responsiveness.
    [Show full text]
  • Possible Involvement in Breast Cancer
    Toxics 2015, 3, 390-413; doi:10.3390/toxics3040390 OPEN ACCESS toxics ISSN 2305-6304 www.mdpi.com/journal/toxics Review Nanotoxicology and Metalloestrogens: Possible Involvement in Breast Cancer David R. Wallace Oklahoma State University Center for Health Sciences, Department of Pharmacology & Physiology, Tulsa, OK 74107-1898, USA; E-Mail: [email protected]; Tel.: +1-918-561-1407; Fax: +1-918-561-5729 Academic Editors: Laura Braydich-Stolle and Saber M. Hussain Received: 14 July 2015 / Accepted: 23 October 2015 / Published: 28 October 2015 Abstract: As the use of nanotechnology has expanded, an increased number of metallic oxides have been manufactured, yet toxicology testing has lagged significantly. Metals used in nano-products include titanium, silicon, aluminum, silver, zinc, cadmium, cobalt, antimony, gold, etc. Even the noble metals, platinum and cerium, have been used as a treatment for cancer, but the toxicity of these metals is still unknown. Significant advances have been made in our understanding and treatment of breast cancer, yet millions of women will experience invasive breast cancer in their lifetime. The pathogenesis of breast cancer can involve multiple factors; (1) genetic; (2) environmental; and (3) lifestyle-related factors. This review focuses on exposure to highly toxic metals, (“metalloestrogens” or “endocrine disruptors”) that are used as the metallic foundation for nanoparticle production and are found in a variety of consumer products such as cosmetics, household items, and processed foods, etc. The linkage between well-understood metalloestrogens such as cadmium, the use of these metals in the production of nanoparticles, and the relationship between their potential estrogenic effects and the development of breast cancer will be explored.
    [Show full text]
  • How Metals in the Environment Could Be Increasing the Risk of Breast Cancer
    How Metals in the Environment Could Be Increasing the Risk of Breast Cancer Summer Research Project by Kate Bohigian Breast Tumor Outline of Presentation 1. Overview 2. Breast Cancer: Non-Invasive vs Invasive 3. Risk Factors of Breast Cancer 4. Estrogen Receptor Positive Breast Cancer 5. Environmental Estrogens 6. Metalloestrogens 7. Metalloestrogens Bind to Estrogen Receptors 8. Cadmium (Example of a Metalloestrogen) 9. Conclusion Breast Cancer: Non-Invasive vs Invasive Non-Invasive Invasive Cancer cells are localized in Cancer cells have left original site lobule or milk duct Risk Factor of Breast Cancer Mammograms showing different densities of cells in the breast High Risk Estrogen Receptor Positive Breast Cancer Environmental Estrogens Phytoestrogens: come Xenoestrogens: come Metalloestrogens: from food from chemicals come from metals Metalloestrogens Sources of Metalloestrogens: Metalloestrogens can trigger cells to become cancerous and decrease their response to medication Metalloestrogens Bind to Estrogen Receptors Cd2+, Cu2+, Se2-, Zn2+, 2+ 2+ 2+ 2+ Co , Cr , Pb , Hg or Ni2+ Cellular Division Cadmium → Estrogen → Increased Risk of Cancer Breast Tumor Conclusion Risk Factor Example of Estrogen Molecule Works Cited Akram, Muhammad et al. "Awareness and current knowledge of breast cancer." Biological research vol. 50,1 33. 2 Oct. 2017, doi:10.1186/s40659-017-0140-9 Byrne, Celia et al. "Metals and breast cancer." Journal of mammary gland biology and neoplasia vol. 18,1 (2013): 63-73. doi:10.1007/s10911-013-9273-9 "Cadmium and Other Metals." Breast Cancer Prevention Partners, 2019, www.bcpp.org/resource/cadmium-and-other-metals/. Accessed 1 Sept. 2020. Florea, Ana-Maria, and Dietrich Büsselberg.
    [Show full text]
  • 8329TCM-A Thermally Conductive Epoxy Adhesive (Part A)
    8329TCM-A Thermally Conductive Epoxy Adhesive (Part A) MG Chemicals UK Limited Version No: A-2.00 Issue Date: 13/05/2021 Safety data sheet according to REACH Regulation (EC) No 1907/2006, as amended by UK REACH Regulations SI 2019/758 Revision Date: 13/05/2021 L.REACH.GB.EN SECTION 1 Identification of the substance / mixture and of the company / undertaking 1.1. Product Identifier Product name 8329TCM-A Synonyms SDS Code: 8329TCM-A; 8329TCM-6ML, 8329TCM-50ML, 8329TCM-200ML | UFI:ATE0-C0S2-J00S-W38T Other means of identification Thermally Conductive Epoxy Adhesive (Part A) 1.2. Relevant identified uses of the substance or mixture and uses advised against Relevant identified uses Thermally conductive adhesive for bonding and thermal management Uses advised against Not Applicable 1.3. Details of the supplier of the safety data sheet Registered company name MG Chemicals UK Limited MG Chemicals (Head office) Heame House, 23 Bilston Street, Sedgely Dudley DY3 1JA United Address 9347 - 193 Street Surrey V4N 4E7 British Columbia Canada Kingdom Telephone +(44) 1663 362888 +(1) 800-201-8822 Fax Not Available +(1) 800-708-9888 Website Not Available www.mgchemicals.com Email [email protected] [email protected] 1.4. Emergency telephone number Association / Organisation Verisk 3E (Access code: 335388) Emergency telephone +(44) 20 35147487 numbers Other emergency telephone +(0) 800 680 0425 numbers SECTION 2 Hazards identification 2.1. Classification of the substance or mixture Classification according to H315 - Skin Corrosion/Irritation Category 2, H319 - Eye Irritation Category 2, H317 - Skin Sensitizer Category 1, H410 - Chronic Aquatic Hazard regulation (EC) No 1272/2008 Category 1 [CLP] and amendments [1] Legend: 1.
    [Show full text]
  • Prof. Lucio Annunziato Phd Thesis Neuroendocrine Axis And
    UNIVERSITY OF NAPLES "FEDERICO II" SCHOOL OF MEDICINE AND SURGERY DEPARTMENT OF NEUROSCIENCE AND REPRODUCTIVE AND ODONTOSTOMATOLOGICAL SCIENCES PhD Program Neuroscience XXIX Cycle Coordinator: Prof. Lucio Annunziato PhD Thesis Neuroendocrine axis and reproduction Tutor Candidate Prof. Carlo Alviggi Dr.ssa Rosaria Borrelli ACADEMIC YEAR 2014-2017 1 INDEX INTRODUCTION CHAPTER I: THE ROLE OF METABOLIC (ENDOGENOUS) VARIABLES ON THE FUNCTION OF THE GONADAL AXIS: THE PCOS MODEL 1. THE POLYCYSTIC OVARY SYNDROME 1.a Epidemiology, risk factors and main endocrine alterations 1.b Diagnostic criteria 1.c Metabolic alterations 2. THE ULTRASONOGRAPHIC FINDINGS RELATED TO INSULIN RESISTANCE IN PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME: A RETROSPECTIVE OBSERVATIONAL STUDY 2.a Scientific background 2.b Patients and Methods 2.c Results 2.d Discussion 2.e Conclusion References CHAPTER II: THE ROLE OF ENVIRONMENTAL FACTORS: THE ENDOMETRIOSIS MODEL 1. ENDOMETRIOSIS 1.a Etiology and pathogenesis 2. THE ROLE OF ENVIRONMENTAL POLLUTANT IN THE PATHOGENESIS OF ENDOMETRIOSIS: A SYSTEMATIC REVIEW OF LITERATURE 2.a Scientific background 2.b Material and Method 2.c Results 2 2.d Discussion 2.e Conclusion References CHAPTER IV: ALTERNATIVE RESEARCH LINE 1. DOES CRYOPRESEVATION INFLUENCE PERINATAL OUTCOMES AFTER BLASTOCYST VERSUS CLEAVAGE STAGE TRANSFER? A SYSTEMATIC REVIEW AND META-ANALYSIS 1.a Introduction 1.b Methods 1.c Results 1.d Discussion 1.e Conclusion References 2. SYNOPSIS GENACOS 2.a Protocol 2.b Objectives 2.c Scientific Background 2.d Methodology References 3 Neuroendocrine axis and reproduction Introduction The physiology of the female reproductive system is regulated by a complex neuro-hormonal interaction whose operative center is the hypothalamus-pituitary-ovarian axis.
    [Show full text]
  • The Protective Role of Melatonin in Cadmium-Induced Proliferation of Ovarian Cancer Cells
    Research in Pharmaceutical Sciences, April 2018; 13(2): 159-167 School of Pharmacy & Pharmaceutical Sciences Received: October 2017 Isfahan University of Medical Sciences Accepted: January 2018 Original Article The protective role of melatonin in cadmium-induced proliferation of ovarian cancer cells Negar Ataei, Mahmoud Aghaei, and Mojtaba Panjehpour* Department of Biochemistry and Bioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran. Abstract Cadmium (Cd), a ubiquitous environmental and occupational pollutant, acts as a metalloestrogen to induce cell proliferation. It is suggested that Cd may also contribute to the development of estrogen-related cancers like ovarian cancer which is the most lethal cancer in women. Furthermore, it was shown that melatonin has antiproliferative effect on estradiol (E2)-induced proliferation. The aim of the present study was to evaluate whether melatonin inhibits Cd-induced proliferation in ovarian cancer cell lines and also whether Cd and melatonin can modulate estrogen receptor α (ERα) expression. OVCAR3 and SKOV3 human ovarian cancer cell lines were treated with CdCl2 (1-100 nM) and melatonin (1 µM) for 48 h. Cell proliferation evaluation was carried out by bromodeoxyuridine (BrdU) incorporation assay. ERα expression was detected by western blotting method 24 h after cell treatment. The results were demonstrated that Cd increased proliferation of ovarian cancer cell lines in a dose dependent manner. Melatonin inhibited Cd-induced proliferation of OVCAR3 and SKOV3 cell lines. Moreover, CdCl2 significantly increased ERα expression in both OVCAR3 and SKOV3 cell lines compared to control. Melatonin significantly inhibited Cd inducing effect on ERα expression of OVCAR3 and SKOV3 cell.
    [Show full text]
  • Sds-834Fx-Part-A En Uk.Pdf
    834FX-A Black Flexible Epoxy, Thermally Conductive–Flame Retardant, Encapsulating and Potting Compound (Part A) MG Chemicals UK Limited Version No: A-1.01 Issue Date: 12/04/2019 Safety Data Sheet (Conforms to Regulation (EU) No 2015/830) Revision Date: 17/03/2020 L.REACH.GBR.EN SECTION 1 IDENTIFICATION OF THE SUBSTANCE / MIXTURE AND OF THE COMPANY / UNDERTAKING 1.1. Product Identifier Product name 834FX-A Synonyms SDS Code: 834FX-Part A, 834FX-450ML, 834FX-1.7L, 834FX-7.4ML, 834FX-40L Other means of identification Black Flexible Epoxy, Thermally Conductive–Flame Retardant, Encapsulating and Potting Compound (Part A) 1.2. Relevant identified uses of the substance or mixture and uses advised against Relevant identified uses epoxy resin Uses advised against Not Applicable 1.3. Details of the supplier of the safety data sheet Registered company name MG Chemicals UK Limited MG Chemicals (Head office) Heame House, 23 Bilston Street, Sedgely Dudley DY3 1JA United Address 9347 - 193 Street Surrey V4N 4E7 British Columbia Canada Kingdom Telephone +(44) 1663 362888 +(1) 800-201-8822 Fax Not Available +(1) 800-708-9888 Website Not Available www.mgchemicals.com Email [email protected] [email protected] 1.4. Emergency telephone number Association / Organisation Verisk 3E (Access code: 335388) Not Available Emergency telephone numbers +(44) 20 35147487 Not Available Other emergency telephone +(0) 800 680 0425 Not Available numbers SECTION 2 HAZARDS IDENTIFICATION 2.1. Classification of the substance or mixture Classification according to H411 - Chronic Aquatic Hazard Category 2, H302 - Acute Toxicity (Oral) Category 4, H315 - Skin Corrosion/Irritation Category 2, H319 - Eye Irritation regulation (EC) No 1272/2008 Category 2, H361 - Reproductive Toxicity Category 2, H317 - Skin Sensitizer Category 1 [CLP] [1] Legend: 1.
    [Show full text]
  • 8329TCM-B Thermally Conductive Epoxy Adhesive
    8329TCM-B Thermally Conductive Epoxy Adhesive (Part B) MG Chemicals UK Limited Version No: A-2.00 Issue Date:13/05/2021 Safety data sheet according to REACH Regulation (EC) No 1907/2006, as amended by UK REACH Regulations SI 2019/758 Revision Date: 13/05/2021 L.REACH.GB.EN SECTION 1 Identification of the substance / mixture and of the company / undertaking 1.1. Product Identifier Product name 8329TCM-B Synonyms SDS Code: 8329TCM-B; 8329TCM-6ML, 8329TCM-50ML, 8329TCM-200ML | UFI:CWE0-V0FF-V008-JEUV Proper shipping name Other means of identification Thermally Conductive Epoxy Adhesive (Part B) 1.2. Relevant identified uses of the substance or mixture and uses advised against Relevant identified uses Thermally conductive adhesive for bonding and thermal management Uses advised against Not Applicable 1.3. Details of the supplier of the safety data sheet Registered company name MG Chemicals UK Limited MG Chemicals (Head office) Heame House, 23 Bilston Street, Sedgely Dudley DY3 1JA United Address 9347 - 193 Street Surrey V4N 4E7 British Columbia Canada Kingdom Telephone +(44) 1663 362888 +(1) 800-201-8822 Fax Not Available +(1) 800-708-9888 Website Not Available www.mgchemicals.com Email [email protected] [email protected] 1.4. Emergency telephone number Association / Organisation Verisk 3E (Access code: 335388) Emergency telephone +(44) 20 35147487 numbers Other emergency telephone +(0) 800 680 0425 numbers SECTION 2 Hazards identification 2.1. Classification of the substance or mixture Classification according to H314 - Skin Corrosion/Irritation Category 1B, H373 - Specific target organ toxicity - repeated exposure Category 2, H361 - Reproductive Toxicity regulation (EC) No 1272/2008 Category 2, H317 - Skin Sensitizer Category 1, H410 - Chronic Aquatic Hazard Category 1 [CLP] and amendments [1] Legend: 1.
    [Show full text]